| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |